Congenital intestinal fibrosarcoma with rapid recurrence requiring adjuvant chemotherapy.

Related Articles

Congenital intestinal fibrosarcoma with rapid recurrence requiring adjuvant chemotherapy.

Pediatr Int. 2017 06;59(6):733-736

Authors: See WSQ, Cheuk DKL, To KF, Ip PP, Chiang AKS, Ha SY, Chan GCF

Abstract
A total of 16 cases of congenital fibrosarcoma have been reported from 1975 to March 2015. Five of the 16 had abnormal fusion between erythroblast transformation specific translocation variant 6 and neurotrophin recptor gene neurotrophic tyrosine kinase, receptor, type 3 (ETV6-NTRK3); in another five out of 16 this was absent, and six were not tested. All were managed by surgical resection but none involved metastasis. Herein we report the case of a newborn baby girl with congenital fibrosarcoma negative for ETV6-NTRK3 gene fusion, who presented with ileal perforation and positive resection margin. She had rapid recurrence with lymph node metastasis treated with postoperative chemotherapy. There was no further recurrence at >3 years of follow up.

PMID: 28436622 [PubMed - indexed for MEDLINE]

http://ift.tt/2FVHYNj